业务
货币单位:人民币
2023/FY
名称营收比例
Oncology drugs21.22亿34.55%
Central nervous system drugs16.95亿27.59%
Cardiovascular system drugs16.87亿27.47%
Alimentary tract and metabolism drugs4.5亿7.33%
其他1.88亿3.07%
地区
货币单位:人民币
2023/FY
名称营收比例
中国内地50.3亿81.87%
欧盟4.5亿7.32%
Asia (other than Mainland China)4.47亿7.27%
其他国家2.17亿3.53%